SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3ibj'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1CRB_A_RTLA200_0 (CELLULAR RETINOL BINDING PROTEIN)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	PHE A 404 LEU A 396 ALA A 400 ILE A 515 ILE A 542	None	1.15A	1crbA-3ibjA: undetectable	1crbA-3ibjA: 11.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DZM_A_BZMA600_0 (ODORANT-BINDING PROTEIN)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 8	ILE A 279 ASN A 351 GLY A 280 LEU A 250	None	0.92A	1dzmA-3ibjA: undetectable	1dzmA-3ibjA: 12.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DZM_A_BZMA600_0 (ODORANT-BINDING PROTEIN)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 8	ILE A 546 ASN A 511 ASN A 509 GLY A 545	None	0.93A	1dzmA-3ibjA: undetectable	1dzmA-3ibjA: 12.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EI6_D_PPFD412_1 (PHOSPHONOACETATE HYDROLASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 8	THR A 768 ASP A 697 HIS A 656 HIS A 660	MG A 905 (-4.3A) ZN A 1 ( 2.9A) None ZN A 1 (-3.4A)	1.02A	1ei6D-3ibjA: undetectable	1ei6D-3ibjA: 20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EQG_A_IBPA701_1 (PROSTAGLANDIN H2 SYNTHASE-1)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 9	VAL A 399 LEU A 396 ILE A 417 ALA A 421 LEU A 424	None	1.07A	1eqgA-3ibjA: undetectable	1eqgA-3ibjA: 20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EQG_B_IBPB1701_1 (PROSTAGLANDIN H2 SYNTHASE-1)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 11	VAL A 399 LEU A 396 ILE A 417 ALA A 421 LEU A 424	None	1.08A	1eqgB-3ibjA: undetectable	1eqgB-3ibjA: 20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TBF_A_VIAA501_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 9	TYR A 655 LEU A 770 LEU A 809 GLN A 859 PHE A 862	None	0.72A	1tbfA-3ibjA: 38.4	1tbfA-3ibjA: 21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1X8V_A_ESLA472_1 (CYTOCHROME P450 51)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 6	MET A 694 LEU A 738 PHE A 746 MET A 761	None	1.08A	1x8vA-3ibjA: undetectable	1x8vA-3ibjA: 20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	7 / 12	TYR A 655 HIS A 656 HIS A 700 LEU A 809 ILE A 826 GLN A 859 PHE A 862	None	0.99A	1xlxA-3ibjA: 32.5	1xlxA-3ibjA: 19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	6 / 12	TYR A 655 HIS A 656 HIS A 700 ILE A 826 GLN A 859 PHE A 862	None	0.68A	1xlxB-3ibjA: 32.4	1xlxB-3ibjA: 19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_A_ROFA101_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	6 / 12	TYR A 655 HIS A 656 ASP A 808 LEU A 809 ILE A 826 PHE A 862	None None ZN A 1 (-2.7A) None None None	0.95A	1xmuA-3ibjA: 32.6	1xmuA-3ibjA: 19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XMU_B_ROFB102_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	TYR A 655 HIS A 656 ASP A 808 LEU A 809 ILE A 826	None None ZN A 1 (-2.7A) None None	0.68A	1xmuB-3ibjA: 32.6	1xmuB-3ibjA: 19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	7 / 12	TYR A 655 HIS A 656 ASP A 808 LEU A 809 ILE A 826 GLN A 859 PHE A 862	None None ZN A 1 (-2.7A) None None None None	1.00A	1xomA-3ibjA: 32.5	1xomA-3ibjA: 18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	6 / 12	TYR A 655 HIS A 656 LEU A 809 ILE A 826 GLN A 859 PHE A 862	None	1.04A	1xomB-3ibjA: 32.8	1xomB-3ibjA: 18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_A_ROFA502_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	6 / 12	TYR A 655 HIS A 656 ASP A 808 LEU A 809 ILE A 826 PHE A 862	None None ZN A 1 (-2.7A) None None None	0.95A	1xoqA-3ibjA: 32.5	1xoqA-3ibjA: 18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_B_ROFB501_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	6 / 12	TYR A 655 HIS A 656 ASP A 808 LEU A 809 ILE A 826 PHE A 862	None None ZN A 1 (-2.7A) None None None	0.98A	1xoqB-3ibjA: 32.7	1xoqB-3ibjA: 18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	6 / 12	TYR A 655 HIS A 656 ASP A 808 GLN A 859 PHE A 862 ILE A 866	None None ZN A 1 (-2.7A) None None None	0.54A	1xosA-3ibjA: 32.7	1xosA-3ibjA: 19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	6 / 12	TYR A 655 HIS A 656 ASP A 808 LEU A 809 PHE A 862 ILE A 866	None None ZN A 1 (-2.7A) None None None	0.74A	1xosA-3ibjA: 32.7	1xosA-3ibjA: 19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	TYR A 655 HIS A 660 GLN A 859 PHE A 862 ILE A 866	None ZN A 1 (-3.4A) None None None	1.49A	1xosA-3ibjA: 32.7	1xosA-3ibjA: 19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_A_VDNA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	7 / 12	TYR A 655 HIS A 656 LEU A 809 ILE A 826 GLN A 859 PHE A 862 ILE A 866	None	0.71A	1xotA-3ibjA: 32.7	1xotA-3ibjA: 19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_B_VDNB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	6 / 12	TYR A 655 HIS A 656 LEU A 809 ILE A 826 GLN A 859 PHE A 862	None	0.85A	1xotB-3ibjA: 32.8	1xotB-3ibjA: 19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOZ_A_CIAA501_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	TYR A 655 ILE A 822 ILE A 855 GLN A 859 PHE A 862	None	0.86A	1xozA-3ibjA: 38.3	1xozA-3ibjA: 22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AYL_A_FLPA1701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	VAL A 399 LEU A 403 LEU A 396 ALA A 421 LEU A 424	None	1.08A	2aylA-3ibjA: 1.0	2aylA-3ibjA: 21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_A_VIAA901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 11	TYR A 655 HIS A 656 ILE A 855 GLN A 859 PHE A 862	None	0.61A	2h42A-3ibjA: 38.3	2h42A-3ibjA: 21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_B_VIAB902_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	TYR A 655 HIS A 656 ILE A 855 GLN A 859 PHE A 862	None	0.58A	2h42B-3ibjA: 38.8	2h42B-3ibjA: 21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_C_VIAC903_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	TYR A 655 LEU A 770 LEU A 809 ILE A 855 PHE A 862	None	0.58A	2h42C-3ibjA: 38.5	2h42C-3ibjA: 21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_C_VIAC903_2 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	3 / 3	ASN A 599 ILE A 596 MET A 622	None	0.81A	2h42C-3ibjA: 38.5	2h42C-3ibjA: 21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HA2_A_SCKA901_1 (ACETYLCHOLINESTERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 8	ASP A 811 TRP A 895 TYR A 655 TYR A 719	None	1.25A	2ha2A-3ibjA: 2.1	2ha2A-3ibjA: 20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q0I_A_BEZA990_0 (QUINOLONE SIGNAL RESPONSE PROTEIN)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 8	ASP A 808 ASP A 697 HIS A 660 SER A 665	ZN A 1 (-2.7A) ZN A 1 ( 2.9A) ZN A 1 (-3.4A) None	1.08A	2q0iA-3ibjA: undetectable	2q0iA-3ibjA: 18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q0J_A_BEZA500_0 (QUINOLONE SIGNAL RESPONSE PROTEIN)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 10	ASP A 808 HIS A 656 ASP A 697 GLU A 727 LEU A 770	ZN A 1 (-2.7A) None ZN A 1 ( 2.9A) None None	1.22A	2q0jA-3ibjA: undetectable	2q0jA-3ibjA: 18.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q6F_C_010C6_0 (INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE N-[(5-METHYLISOXAZOL -3-YL)CARBONYL]ALANY L-L-VALYL-N~1~-((1R, 2Z)-4-(BENZYLOXY)-4- OXO-1-{[(3R)-2-OXOPY RROLIDIN-3-YL]METHYL }BUT-2-ENYL)-L-LEUCI NAMIDE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	3 / 3	ASN A 704 LEU A 718 HIS A 656	None	0.84A	2q6fB-3ibjA: undetectable	2q6fB-3ibjA: 17.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_E_ASDE1224_1 (GLUTATHIONE S-TRANSFERASE A3)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 9	PHE A 505 LEU A 403 LEU A 414 ALA A 421 ALA A 518	None	1.30A	2vcvE-3ibjA: undetectable	2vcvE-3ibjA: 15.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_H_ASDH1224_1 (GLUTATHIONE S-TRANSFERASE A3)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 9	PHE A 505 LEU A 403 LEU A 414 ALA A 421 ALA A 518	None	1.27A	2vcvH-3ibjA: undetectable	2vcvH-3ibjA: 15.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_A_EV1A1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	8 / 12	HIS A 656 LEU A 770 LEU A 809 ILE A 826 TYR A 827 GLU A 829 GLN A 859 PHE A 862	None	0.77A	2weyA-3ibjA: 36.6	2weyA-3ibjA: 21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_A_EV1A1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	8 / 12	TYR A 655 HIS A 656 LEU A 809 ILE A 826 TYR A 827 GLU A 829 GLN A 859 PHE A 862	None	0.72A	2weyA-3ibjA: 36.6	2weyA-3ibjA: 21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_B_EV1B1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 8	LEU A 623 VAL A 646 PHE A 746 MET A 757	None	0.93A	2weyB-3ibjA: 36.4	2weyB-3ibjA: 21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_B_EV1B1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 8	LEU A 770 ILE A 826 TYR A 827 GLN A 859 PHE A 862	None	0.78A	2weyB-3ibjA: 36.4	2weyB-3ibjA: 21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B2R_A_VDNA1_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	6 / 12	TYR A 655 HIS A 656 LEU A 809 ILE A 855 GLN A 859 PHE A 862	None	0.85A	3b2rA-3ibjA: 36.7	3b2rA-3ibjA: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B2R_B_VDNB1_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 11	TYR A 655 HIS A 656 LEU A 809 GLN A 859 PHE A 862	None	0.68A	3b2rB-3ibjA: 36.7	3b2rB-3ibjA: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B2R_B_VDNB1_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 11	TYR A 655 HIS A 656 LEU A 809 ILE A 855 PHE A 862	None	0.60A	3b2rB-3ibjA: 36.7	3b2rB-3ibjA: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDY_A_RBFA187_1 (LUMAZINE PROTEIN)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	VAL A 577 CYH A 643 ILE A 745 ASP A 635 ILE A 619	None	1.08A	3ddyA-3ibjA: undetectable	3ddyA-3ibjA: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_B_ROFB902_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	6 / 12	TYR A 655 HIS A 656 ASP A 808 LEU A 809 ILE A 826 PHE A 862	None None ZN A 1 (-2.7A) None None None	0.92A	3g4lB-3ibjA: 32.7	3g4lB-3ibjA: 17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_C_ROFC903_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	TYR A 655 HIS A 656 ASP A 808 LEU A 809 ILE A 826	None None ZN A 1 (-2.7A) None None	0.72A	3g4lC-3ibjA: 32.5	3g4lC-3ibjA: 17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_D_ROFD904_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	6 / 12	TYR A 655 HIS A 656 ASP A 808 LEU A 809 ILE A 826 GLN A 859	None None ZN A 1 (-2.7A) None None None	0.93A	3g4lD-3ibjA: 32.8	3g4lD-3ibjA: 17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IAK_A_EV1A415_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 9	TYR A 655 ILE A 826 GLN A 859 PHE A 862 ILE A 866	None	0.68A	3iakA-3ibjA: 32.0	3iakA-3ibjA: 18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_A_VIAA901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 9	TYR A 655 HIS A 656 LEU A 770 GLN A 859 PHE A 862	None	0.67A	3jwqA-3ibjA: 38.5	3jwqA-3ibjA: 21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_B_VIAB901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 11	TYR A 655 HIS A 656 LEU A 770 GLN A 859 PHE A 862	None	0.68A	3jwqB-3ibjA: 38.5 3jwqC-3ibjA: 38.4	3jwqB-3ibjA: 21.08 3jwqC-3ibjA: 21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_C_VIAC901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 7	TYR A 655 HIS A 656 GLN A 859 PHE A 862	None	0.33A	3jwqC-3ibjA: 38.4	3jwqC-3ibjA: 21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_D_VIAD901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 11	TYR A 655 HIS A 656 LEU A 770 GLN A 859 PHE A 862	None	0.69A	3jwqA-3ibjA: 38.5 3jwqD-3ibjA: 38.4	3jwqA-3ibjA: 21.08 3jwqD-3ibjA: 21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N58_A_ADNA500_2 (ADENOSYLHOMOCYSTEINA SE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 5	THR A 703 GLU A 727 THR A 768 HIS A 696	None None MG A 905 (-4.3A) ZN A 1 (-3.5A)	1.36A	3n58A-3ibjA: undetectable	3n58A-3ibjA: 20.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NT1_A_NPSA5_1 (PROSTAGLANDIN-ENDOPE ROXIDE SYNTHASE 2)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	VAL A 399 LEU A 403 LEU A 396 ALA A 421 LEU A 424	None	1.00A	3nt1A-3ibjA: undetectable	3nt1A-3ibjA: 21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NT1_B_NPSB4_1 (PROSTAGLANDIN-ENDOPE ROXIDE SYNTHASE 2)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	VAL A 399 LEU A 403 LEU A 396 ALA A 421 LEU A 424	None	1.00A	3nt1B-3ibjA: undetectable	3nt1B-3ibjA: 21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RD0_A_EDPA175_1 (FERRITIN LIGHT CHAIN)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 6	LEU A 671 TYR A 672 ALA A 601 LEU A 677	None	1.11A	3rd0A-3ibjA: undetectable	3rd0A-3ibjA: 14.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TVX_A_PNXA902_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 9	TYR A 655 LEU A 809 ILE A 826 GLN A 859 PHE A 862	None	0.76A	3tvxA-3ibjA: 33.1	3tvxA-3ibjA: 18.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TVX_B_PNXB902_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 7	TYR A 655 ILE A 826 GLN A 859 PHE A 862	None	0.59A	3tvxB-3ibjA: 33.0	3tvxB-3ibjA: 18.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_A_W9TA1002_1 (HEMOLYTIC LECTIN CEL-III)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	3 / 3	ASP A 769 GLU A 722 GLY A 723	None	0.66A	3w9tA-3ibjA: undetectable	3w9tA-3ibjA: 19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WRK_D_CAMD502_0 (CAMPHOR 5-MONOOXYGENASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 5	PHE A 370 LEU A 250 THR A 257 VAL A 365	None	0.94A	3wrkD-3ibjA: undetectable	3wrkD-3ibjA: 20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	SER A 541 THR A 405 SER A 551 PHE A 404 HIS A 406	None	1.45A	4c49B-3ibjA: undetectable	4c49B-3ibjA: 19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GKH_D_KAND301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 8	ASP A 356 CYH A 325 GLU A 326 GLU A 354	None	0.96A	4gkhD-3ibjA: undetectable	4gkhD-3ibjA: 17.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GKI_G_KANG301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 8	ASP A 360 ASP A 310 ASP A 302 GLU A 363	None	1.15A	4gkiE-3ibjA: undetectable 4gkiG-3ibjA: undetectable	4gkiE-3ibjA: 17.70 4gkiG-3ibjA: 17.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HDL_A_DXCA75_0 (PPCA)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 8	ILE A 765 ILE A 735 MET A 645 GLY A 649	None	0.87A	4hdlA-3ibjA: undetectable	4hdlA-3ibjA: 8.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JVL_A_ESTA702_1 (ESTROGEN SULFOTRANSFERASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 9	PHE A 642 CYH A 643 PHE A 687 ILE A 629	None	0.86A	4jvlA-3ibjA: undetectable	4jvlA-3ibjA: 17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LVC_A_ADNA501_2 (S-ADENOSYL-L-HOMOCYS TEINE HYDROLASE (SAHASE))	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 5	GLN A 875 THR A 805 HIS A 773 LEU A 780	None	1.19A	4lvcA-3ibjA: undetectable	4lvcA-3ibjA: 20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LVC_C_ADNC501_2 (S-ADENOSYL-L-HOMOCYS TEINE HYDROLASE (SAHASE))	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 5	GLN A 875 THR A 805 HIS A 773 LEU A 780	None	1.21A	4lvcC-3ibjA: undetectable	4lvcC-3ibjA: 20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QB9_A_PARA500_1 (ENHANCED INTRACELLULAR SURVIVAL PROTEIN)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 10	PHE A 707 PHE A 831 THR A 703 GLU A 727 TYR A 719	None	1.26A	4qb9A-3ibjA: 0.0	4qb9A-3ibjA: 20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QB9_E_PARE500_1 (ENHANCED INTRACELLULAR SURVIVAL PROTEIN)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	PHE A 707 PHE A 831 THR A 703 GLU A 727 TYR A 719	None	1.26A	4qb9E-3ibjA: undetectable	4qb9E-3ibjA: 20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RP8_C_ASCC501_0 (ASCORBATE-SPECIFIC PERMEASE IIC COMPONENT ULAA)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	LEU A 639 ILE A 619 ILE A 634 ILE A 691 PHE A 687	None	1.19A	4rp8C-3ibjA: 1.4	4rp8C-3ibjA: 20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H8T_A_RTLA201_0 (RETINOL-BINDING PROTEIN 1)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	PHE A 404 LEU A 396 ALA A 400 ILE A 515 ILE A 542	None	1.16A	5h8tA-3ibjA: undetectable	5h8tA-3ibjA: 12.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HBS_A_RTLA201_0 (RETINOL-BINDING PROTEIN 1)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	PHE A 404 LEU A 396 ALA A 400 ILE A 515 ILE A 542	None	1.09A	5hbsA-3ibjA: undetectable	5hbsA-3ibjA: 12.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JM4_A_BEZA301_0 (14-3-3 PROTEIN ZETA/DELTA)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 5	PHE A 731 ILE A 735 MET A 761 ARG A 762	None	0.82A	5jm4A-3ibjA: 3.4	5jm4A-3ibjA: 17.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KIR_B_RCXB601_2 (PROSTAGLANDIN G/H SYNTHASE 2)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 4	LEU A 738 ARG A 641 ILE A 737 PHE A 642	None	1.12A	5kirB-3ibjA: undetectable	5kirB-3ibjA: 20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MWY_A_YNUA1101_1 (MINERALOCORTICOID RECEPTOR)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 6	GLN A 463 PHE A 433 THR A 499 PHE A 487	None	1.22A	5mwyA-3ibjA: undetectable	5mwyA-3ibjA: 19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NEK_B_AZMB302_1 (PEPTIDOGLYCAN N-ACETYLGLUCOSAMINE DEACETYLASE)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 8	ASP A 697 HIS A 656 ARG A 728 HIS A 730	ZN A 1 ( 2.9A) None None None	0.99A	5nekB-3ibjA: undetectable	5nekB-3ibjA: 8.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TQR_B_SAMB8009_0 (HISTONE-LYSINE N-METHYLTRANSFERASE EZH2, POLYCOMB PROTEIN SUZ12)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 10	LEU A 231 CYH A 234 GLY A 235 TYR A 238 VAL A 376	None	1.48A	5tqrB-3ibjA: 3.0	5tqrB-3ibjA: 22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UHC_C_RFPC1201_2 (DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	3 / 3	PHE A 777 ASP A 779 LEU A 766	None	0.76A	5uhcC-3ibjA: undetectable	5uhcC-3ibjA: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y2T_A_8LXA501_0 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	LEU A 284 GLY A 324 CYH A 325 GLN A 320 LEU A 308	None	1.28A	5y2tA-3ibjA: undetectable	5y2tA-3ibjA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YCP_A_BRLA501_0 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	SER A 665 LEU A 623 ILE A 686 LEU A 698 TYR A 650	None	1.34A	5ycpA-3ibjA: undetectable	5ycpA-3ibjA: 8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6F8C_A_STRA502_1 (CYTOCHROME P450 CYP260A1)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 6	SER A 260 THR A 257 ILE A 366 PHE A 370	None	0.82A	6f8cA-3ibjA: undetectable	6f8cA-3ibjA: 9.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GBN_A_ADNA501_2 (-)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 5	GLN A 875 THR A 805 HIS A 773 LEU A 780	None	1.23A	6gbnA-3ibjA: undetectable	6gbnA-3ibjA: 21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GBN_D_ADND501_2 (-)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	4 / 5	GLN A 875 THR A 805 HIS A 773 LEU A 780	None	1.24A	6gbnD-3ibjA: undetectable	6gbnD-3ibjA: 21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNG_B_QPSB601_3 (-)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	3 / 3	ASP A 683 ASP A 625 ASN A 599	None	0.86A	6gngB-3ibjA: undetectable	6gngB-3ibjA: 21.79

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1CRB_A_RTLA200_0","CELLULAR RETINOL BINDING PROTEIN","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"PHE A 404;LEU A 396;ALA A 400;ILE A 515;ILE A 542","None","1.15A","1crbA-3ibjA:undetectable","1crbA-3ibjA:11.79"],["1DZM_A_BZMA600_0","ODORANT-BINDING PROTEIN","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"ILE A 279;ASN A 351;GLY A 280;LEU A 250","None","0.92A","1dzmA-3ibjA:undetectable","1dzmA-3ibjA:12.88"],["1DZM_A_BZMA600_0","ODORANT-BINDING PROTEIN","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"ILE A 546;ASN A 511;ASN A 509;GLY A 545","None","0.93A","1dzmA-3ibjA:undetectable","1dzmA-3ibjA:12.88"],["1EI6_D_PPFD412_1","PHOSPHONOACETATE HYDROLASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"THR A 768;ASP A 697;HIS A 656;HIS A 660"," MG A 905 (-4.3A); ZN A   1 ( 2.9A);None; ZN A   1 (-3.4A)","1.02A","1ei6D-3ibjA:undetectable","1ei6D-3ibjA:20.83"],["1EQG_A_IBPA701_1","PROSTAGLANDIN H2 SYNTHASE-1","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"VAL A 399;LEU A 396;ILE A 417;ALA A 421;LEU A 424","None","1.07A","1eqgA-3ibjA:undetectable","1eqgA-3ibjA:20.45"],["1EQG_B_IBPB1701_1","PROSTAGLANDIN H2 SYNTHASE-1","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"VAL A 399;LEU A 396;ILE A 417;ALA A 421;LEU A 424","None","1.08A","1eqgB-3ibjA:undetectable","1eqgB-3ibjA:20.45"],["1TBF_A_VIAA501_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;LEU A 770;LEU A 809;GLN A 859;PHE A 862","None","0.72A","1tbfA-3ibjA:38.4","1tbfA-3ibjA:21.91"],["1X8V_A_ESLA472_1","CYTOCHROME P450 51","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"MET A 694;LEU A 738;PHE A 746;MET A 761","None","1.08A","1x8vA-3ibjA:undetectable","1x8vA-3ibjA:20.82"],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",7,"TYR A 655;HIS A 656;HIS A 700;LEU A 809;ILE A 826;GLN A 859;PHE A 862","None","0.99A","1xlxA-3ibjA:32.5","1xlxA-3ibjA:19.40"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",6,"TYR A 655;HIS A 656;HIS A 700;ILE A 826;GLN A 859;PHE A 862","None","0.68A","1xlxB-3ibjA:32.4","1xlxB-3ibjA:19.40"],["1XMU_A_ROFA101_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",6,"TYR A 655;HIS A 656;ASP A 808;LEU A 809;ILE A 826;PHE A 862","None;None; ZN A   1 (-2.7A);None;None;None","0.95A","1xmuA-3ibjA:32.6","1xmuA-3ibjA:19.40"],["1XMU_B_ROFB102_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;HIS A 656;ASP A 808;LEU A 809;ILE A 826","None;None; ZN A   1 (-2.7A);None;None","0.68A","1xmuB-3ibjA:32.6","1xmuB-3ibjA:19.40"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",7,"TYR A 655;HIS A 656;ASP A 808;LEU A 809;ILE A 826;GLN A 859;PHE A 862","None;None; ZN A   1 (-2.7A);None;None;None;None","1.00A","1xomA-3ibjA:32.5","1xomA-3ibjA:18.88"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",6,"TYR A 655;HIS A 656;LEU A 809;ILE A 826;GLN A 859;PHE A 862","None","1.04A","1xomB-3ibjA:32.8","1xomB-3ibjA:18.88"],["1XOQ_A_ROFA502_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",6,"TYR A 655;HIS A 656;ASP A 808;LEU A 809;ILE A 826;PHE A 862","None;None; ZN A   1 (-2.7A);None;None;None","0.95A","1xoqA-3ibjA:32.5","1xoqA-3ibjA:18.88"],["1XOQ_B_ROFB501_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",6,"TYR A 655;HIS A 656;ASP A 808;LEU A 809;ILE A 826;PHE A 862","None;None; ZN A   1 (-2.7A);None;None;None","0.98A","1xoqB-3ibjA:32.7","1xoqB-3ibjA:18.88"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",6,"TYR A 655;HIS A 656;ASP A 808;GLN A 859;PHE A 862;ILE A 866","None;None; ZN A   1 (-2.7A);None;None;None","0.54A","1xosA-3ibjA:32.7","1xosA-3ibjA:19.40"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",6,"TYR A 655;HIS A 656;ASP A 808;LEU A 809;PHE A 862;ILE A 866","None;None; ZN A   1 (-2.7A);None;None;None","0.74A","1xosA-3ibjA:32.7","1xosA-3ibjA:19.40"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;HIS A 660;GLN A 859;PHE A 862;ILE A 866","None; ZN A   1 (-3.4A);None;None;None","1.49A","1xosA-3ibjA:32.7","1xosA-3ibjA:19.40"],["1XOT_A_VDNA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",7,"TYR A 655;HIS A 656;LEU A 809;ILE A 826;GLN A 859;PHE A 862;ILE A 866","None","0.71A","1xotA-3ibjA:32.7","1xotA-3ibjA:19.40"],["1XOT_B_VDNB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",6,"TYR A 655;HIS A 656;LEU A 809;ILE A 826;GLN A 859;PHE A 862","None","0.85A","1xotB-3ibjA:32.8","1xotB-3ibjA:19.40"],["1XOZ_A_CIAA501_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;ILE A 822;ILE A 855;GLN A 859;PHE A 862","None","0.86A","1xozA-3ibjA:38.3","1xozA-3ibjA:22.04"],["2AYL_A_FLPA1701_1","PROSTAGLANDIN G\/H SYNTHASE 1","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"VAL A 399;LEU A 403;LEU A 396;ALA A 421;LEU A 424","None","1.08A","2aylA-3ibjA:1.0","2aylA-3ibjA:21.51"],["2H42_A_VIAA901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;HIS A 656;ILE A 855;GLN A 859;PHE A 862","None","0.61A","2h42A-3ibjA:38.3","2h42A-3ibjA:21.11"],["2H42_B_VIAB902_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;HIS A 656;ILE A 855;GLN A 859;PHE A 862","None","0.58A","2h42B-3ibjA:38.8","2h42B-3ibjA:21.11"],["2H42_C_VIAC903_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;LEU A 770;LEU A 809;ILE A 855;PHE A 862","None","0.58A","2h42C-3ibjA:38.5","2h42C-3ibjA:21.11"],["2H42_C_VIAC903_2","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",3,"ASN A 599;ILE A 596;MET A 622","None","0.81A","2h42C-3ibjA:38.5","2h42C-3ibjA:21.11"],["2HA2_A_SCKA901_1","ACETYLCHOLINESTERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"ASP A 811;TRP A 895;TYR A 655;TYR A 719","None","1.25A","2ha2A-3ibjA:2.1","2ha2A-3ibjA:20.38"],["2Q0I_A_BEZA990_0","QUINOLONE SIGNAL RESPONSE PROTEIN","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"ASP A 808;ASP A 697;HIS A 660;SER A 665"," ZN A   1 (-2.7A); ZN A   1 ( 2.9A); ZN A   1 (-3.4A);None","1.08A","2q0iA-3ibjA:undetectable","2q0iA-3ibjA:18.50"],["2Q0J_A_BEZA500_0","QUINOLONE SIGNAL RESPONSE PROTEIN","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"ASP A 808;HIS A 656;ASP A 697;GLU A 727;LEU A 770"," ZN A   1 (-2.7A);None; ZN A   1 ( 2.9A);None;None","1.22A","2q0jA-3ibjA:undetectable","2q0jA-3ibjA:18.79"],["2Q6F_C_010C6_0","INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE;N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",3,"ASN A 704;LEU A 718;HIS A 656","None","0.84A","2q6fB-3ibjA:undetectable","2q6fB-3ibjA:17.93"],["2VCV_E_ASDE1224_1","GLUTATHIONE S-TRANSFERASE A3","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"PHE A 505;LEU A 403;LEU A 414;ALA A 421;ALA A 518","None","1.30A","2vcvE-3ibjA:undetectable","2vcvE-3ibjA:15.33"],["2VCV_H_ASDH1224_1","GLUTATHIONE S-TRANSFERASE A3","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"PHE A 505;LEU A 403;LEU A 414;ALA A 421;ALA A 518","None","1.27A","2vcvH-3ibjA:undetectable","2vcvH-3ibjA:15.33"],["2WEY_A_EV1A1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",8,"HIS A 656;LEU A 770;LEU A 809;ILE A 826;TYR A 827;GLU A 829;GLN A 859;PHE A 862","None","0.77A","2weyA-3ibjA:36.6","2weyA-3ibjA:21.84"],["2WEY_A_EV1A1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",8,"TYR A 655;HIS A 656;LEU A 809;ILE A 826;TYR A 827;GLU A 829;GLN A 859;PHE A 862","None","0.72A","2weyA-3ibjA:36.6","2weyA-3ibjA:21.84"],["2WEY_B_EV1B1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"LEU A 623;VAL A 646;PHE A 746;MET A 757","None","0.93A","2weyB-3ibjA:36.4","2weyB-3ibjA:21.84"],["2WEY_B_EV1B1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"LEU A 770;ILE A 826;TYR A 827;GLN A 859;PHE A 862","None","0.78A","2weyB-3ibjA:36.4","2weyB-3ibjA:21.84"],["3B2R_A_VDNA1_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",6,"TYR A 655;HIS A 656;LEU A 809;ILE A 855;GLN A 859;PHE A 862","None","0.85A","3b2rA-3ibjA:36.7","3b2rA-3ibjA:21.23"],["3B2R_B_VDNB1_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;HIS A 656;LEU A 809;GLN A 859;PHE A 862","None","0.68A","3b2rB-3ibjA:36.7","3b2rB-3ibjA:21.23"],["3B2R_B_VDNB1_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;HIS A 656;LEU A 809;ILE A 855;PHE A 862","None","0.60A","3b2rB-3ibjA:36.7","3b2rB-3ibjA:21.23"],["3DDY_A_RBFA187_1","LUMAZINE PROTEIN","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"VAL A 577;CYH A 643;ILE A 745;ASP A 635;ILE A 619","None","1.08A","3ddyA-3ibjA:undetectable","3ddyA-3ibjA:14.76"],["3G4L_B_ROFB902_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",6,"TYR A 655;HIS A 656;ASP A 808;LEU A 809;ILE A 826;PHE A 862","None;None; ZN A   1 (-2.7A);None;None;None","0.92A","3g4lB-3ibjA:32.7","3g4lB-3ibjA:17.41"],["3G4L_C_ROFC903_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;HIS A 656;ASP A 808;LEU A 809;ILE A 826","None;None; ZN A   1 (-2.7A);None;None","0.72A","3g4lC-3ibjA:32.5","3g4lC-3ibjA:17.41"],["3G4L_D_ROFD904_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",6,"TYR A 655;HIS A 656;ASP A 808;LEU A 809;ILE A 826;GLN A 859","None;None; ZN A   1 (-2.7A);None;None;None","0.93A","3g4lD-3ibjA:32.8","3g4lD-3ibjA:17.41"],["3IAK_A_EV1A415_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;ILE A 826;GLN A 859;PHE A 862;ILE A 866","None","0.68A","3iakA-3ibjA:32.0","3iakA-3ibjA:18.88"],["3JWQ_A_VIAA901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;HIS A 656;LEU A 770;GLN A 859;PHE A 862","None","0.67A","3jwqA-3ibjA:38.5","3jwqA-3ibjA:21.08"],["3JWQ_B_VIAB901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA;CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;HIS A 656;LEU A 770;GLN A 859;PHE A 862","None","0.68A","3jwqB-3ibjA:38.5;3jwqC-3ibjA:38.4","3jwqB-3ibjA:21.08;3jwqC-3ibjA:21.08"],["3JWQ_C_VIAC901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"TYR A 655;HIS A 656;GLN A 859;PHE A 862","None","0.33A","3jwqC-3ibjA:38.4","3jwqC-3ibjA:21.08"],["3JWQ_D_VIAD901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA;CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;HIS A 656;LEU A 770;GLN A 859;PHE A 862","None","0.69A","3jwqA-3ibjA:38.5;3jwqD-3ibjA:38.4","3jwqA-3ibjA:21.08;3jwqD-3ibjA:21.08"],["3N58_A_ADNA500_2","ADENOSYLHOMOCYSTEINASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"THR A 703;GLU A 727;THR A 768;HIS A 696","None;None; MG A 905 (-4.3A); ZN A   1 (-3.5A)","1.36A","3n58A-3ibjA:undetectable","3n58A-3ibjA:20.80"],["3NT1_A_NPSA5_1","PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"VAL A 399;LEU A 403;LEU A 396;ALA A 421;LEU A 424","None","1.00A","3nt1A-3ibjA:undetectable","3nt1A-3ibjA:21.65"],["3NT1_B_NPSB4_1","PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"VAL A 399;LEU A 403;LEU A 396;ALA A 421;LEU A 424","None","1.00A","3nt1B-3ibjA:undetectable","3nt1B-3ibjA:21.65"],["3RD0_A_EDPA175_1","FERRITIN LIGHT CHAIN","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"LEU A 671;TYR A 672;ALA A 601;LEU A 677","None","1.11A","3rd0A-3ibjA:undetectable","3rd0A-3ibjA:14.65"],["3TVX_A_PNXA902_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"TYR A 655;LEU A 809;ILE A 826;GLN A 859;PHE A 862","None","0.76A","3tvxA-3ibjA:33.1","3tvxA-3ibjA:18.26"],["3TVX_B_PNXB902_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"TYR A 655;ILE A 826;GLN A 859;PHE A 862","None","0.59A","3tvxB-3ibjA:33.0","3tvxB-3ibjA:18.26"],["3W9T_A_W9TA1002_1","HEMOLYTIC LECTIN CEL-III","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",3,"ASP A 769;GLU A 722;GLY A 723","None","0.66A","3w9tA-3ibjA:undetectable","3w9tA-3ibjA:19.66"],["3WRK_D_CAMD502_0","CAMPHOR 5-MONOOXYGENASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"PHE A 370;LEU A 250;THR A 257;VAL A 365","None","0.94A","3wrkD-3ibjA:undetectable","3wrkD-3ibjA:20.57"],["4C49_B_HCYB1384_1","CORTICOSTEROID-BINDING GLOBULIN","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"SER A 541;THR A 405;SER A 551;PHE A 404;HIS A 406","None","1.45A","4c49B-3ibjA:undetectable","4c49B-3ibjA:19.71"],["4GKH_D_KAND301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"ASP A 356;CYH A 325;GLU A 326;GLU A 354","None","0.96A","4gkhD-3ibjA:undetectable","4gkhD-3ibjA:17.70"],["4GKI_G_KANG301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB;AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"ASP A 360;ASP A 310;ASP A 302;GLU A 363","None","1.15A","4gkiE-3ibjA:undetectable;4gkiG-3ibjA:undetectable","4gkiE-3ibjA:17.70;4gkiG-3ibjA:17.70"],["4HDL_A_DXCA75_0","PPCA","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"ILE A 765;ILE A 735;MET A 645;GLY A 649","None","0.87A","4hdlA-3ibjA:undetectable","4hdlA-3ibjA:8.13"],["4JVL_A_ESTA702_1","ESTROGEN SULFOTRANSFERASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"PHE A 642;CYH A 643;PHE A 687;ILE A 629","None","0.86A","4jvlA-3ibjA:undetectable","4jvlA-3ibjA:17.05"],["4LVC_A_ADNA501_2","S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (SAHASE)","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"GLN A 875;THR A 805;HIS A 773;LEU A 780","None","1.19A","4lvcA-3ibjA:undetectable","4lvcA-3ibjA:20.99"],["4LVC_C_ADNC501_2","S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (SAHASE)","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"GLN A 875;THR A 805;HIS A 773;LEU A 780","None","1.21A","4lvcC-3ibjA:undetectable","4lvcC-3ibjA:20.99"],["4QB9_A_PARA500_1","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"PHE A 707;PHE A 831;THR A 703;GLU A 727;TYR A 719","None","1.26A","4qb9A-3ibjA:0.0","4qb9A-3ibjA:20.63"],["4QB9_E_PARE500_1","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"PHE A 707;PHE A 831;THR A 703;GLU A 727;TYR A 719","None","1.26A","4qb9E-3ibjA:undetectable","4qb9E-3ibjA:20.63"],["4RP8_C_ASCC501_0","ASCORBATE-SPECIFIC PERMEASE IIC COMPONENT ULAA","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"LEU A 639;ILE A 619;ILE A 634;ILE A 691;PHE A 687","None","1.19A","4rp8C-3ibjA:1.4","4rp8C-3ibjA:20.89"],["5H8T_A_RTLA201_0","RETINOL-BINDING PROTEIN 1","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"PHE A 404;LEU A 396;ALA A 400;ILE A 515;ILE A 542","None","1.16A","5h8tA-3ibjA:undetectable","5h8tA-3ibjA:12.23"],["5HBS_A_RTLA201_0","RETINOL-BINDING PROTEIN 1","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"PHE A 404;LEU A 396;ALA A 400;ILE A 515;ILE A 542","None","1.09A","5hbsA-3ibjA:undetectable","5hbsA-3ibjA:12.23"],["5JM4_A_BEZA301_0","14-3-3 PROTEIN ZETA\/DELTA","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"PHE A 731;ILE A 735;MET A 761;ARG A 762","None","0.82A","5jm4A-3ibjA:3.4","5jm4A-3ibjA:17.15"],["5KIR_B_RCXB601_2","PROSTAGLANDIN G\/H SYNTHASE 2","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"LEU A 738;ARG A 641;ILE A 737;PHE A 642","None","1.12A","5kirB-3ibjA:undetectable","5kirB-3ibjA:20.97"],["5MWY_A_YNUA1101_1","MINERALOCORTICOID RECEPTOR","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"GLN A 463;PHE A 433;THR A 499;PHE A 487","None","1.22A","5mwyA-3ibjA:undetectable","5mwyA-3ibjA:19.61"],["5NEK_B_AZMB302_1","PEPTIDOGLYCAN N-ACETYLGLUCOSAMINE DEACETYLASE","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"ASP A 697;HIS A 656;ARG A 728;HIS A 730"," ZN A   1 ( 2.9A);None;None;None","0.99A","5nekB-3ibjA:undetectable","5nekB-3ibjA:8.87"],["5TQR_B_SAMB8009_0","HISTONE-LYSINE N-METHYLTRANSFERASE EZH2, POLYCOMB PROTEIN SUZ12","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"LEU A 231;CYH A 234;GLY A 235;TYR A 238;VAL A 376","None","1.48A","5tqrB-3ibjA:3.0","5tqrB-3ibjA:22.88"],["5UHC_C_RFPC1201_2","DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",3,"PHE A 777;ASP A 779;LEU A 766","None","0.76A","5uhcC-3ibjA:undetectable","5uhcC-3ibjA:20.50"],["5Y2T_A_8LXA501_0","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"LEU A 284;GLY A 324;CYH A 325;GLN A 320;LEU A 308","None","1.28A","5y2tA-3ibjA:undetectable","5y2tA-3ibjA:undetectable"],["5YCP_A_BRLA501_0","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",5,"SER A 665;LEU A 623;ILE A 686;LEU A 698;TYR A 650","None","1.34A","5ycpA-3ibjA:undetectable","5ycpA-3ibjA:8.16"],["6F8C_A_STRA502_1","CYTOCHROME P450 CYP260A1","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"SER A 260;THR A 257;ILE A 366;PHE A 370","None","0.82A","6f8cA-3ibjA:undetectable","6f8cA-3ibjA:9.94"],["6GBN_A_ADNA501_2","-","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"GLN A 875;THR A 805;HIS A 773;LEU A 780","None","1.23A","6gbnA-3ibjA:undetectable","6gbnA-3ibjA:21.79"],["6GBN_D_ADND501_2","-","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",4,"GLN A 875;THR A 805;HIS A 773;LEU A 780","None","1.24A","6gbnD-3ibjA:undetectable","6gbnD-3ibjA:21.79"],["6GNG_B_QPSB601_3","-","3ibj","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","Homo sapiens",3,"ASP A 683;ASP A 625;ASN A 599","None","0.86A","6gngB-3ibjA:undetectable","6gngB-3ibjA:21.79"]]